Dan-Feng Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dan-Feng Wang has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Fu-Shan Xue
Department of Anesthesiology, Beijing Friendship Hospital, Capital Medical University, Beijing, People’s Republic of China
5 shared publications - Xiao-Chun Zheng
Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Hospital, Fuzhou, China
3 shared publications - Xiaochun Zheng
Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China
3 shared publications Ling Zheng
Department of Anesthesiology/Critical Care Medicine, School of Medicine, Fujian Provincial Key Laboratory of Critical Care Medicine, Fuzhou University Affiliated Provincial Hospital, Fuzhou University, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, China
2 shared publicationsPingting Huang
Department of Emergency Medicine, Fujian Provincial Hospital, Fujian Provincial Key Laboratory of Emergency Medicine, Shengli Clinical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China
2 shared publications- Xiaobin Fang
Department of Anesthesiology/Critical Care Medicine, Fuzhou University Affiliated Provincial Hospital, School of Medicine, Fuzhou University, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Key Laboratory of Critical Care Medicine, Fujian Provincial Hospital, No. 134 Dongjie Street, Gulou District, Fuzhou, Fujian 350001
2 shared publications
Latest Publications
- Open Access
- 12 August 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
CD63 aptamer–based electrochemical sensor assesses stored red blood cell–derived exosome burden associated with mast-cell–mediated transfusion-related acute lung injury
- 12 August 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Open AccessCD63 aptamer–based electrochemical sensor assesses stored red blood cell–derived exosome burden associated with mast-cell–mediated transfusion-related acute lung injury
- 14 July 2026
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 255, 51-66
GPX3 downregulation in alveolar macrophages amplifies IL-17–dependent redox–inflammation crosstalk in ARDS
- 14 July 2026
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 255, 51-66
GPX3 downregulation in alveolar macrophages amplifies IL-17–dependent redox–inflammation crosstalk in ARDS
- Open Access
- 12 January 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1684794
Bilateral thoracic paravertebral block for robotic hepatectomy without hepatic portal occlusion for a cirrhosis patient: a case report
Background: Bilateral thoracic paravertebral block (TPVB) is a regional anesthesia technique used for perioperative analgesia in thoracic and abdominal surgeries. However, its application as a key component of anesthesia to optimize surgical conditions during robotic-assisted hepatectomy, particularly in patients with severe liver cirrhosis, is not well-documented. Case presentation: We present the successful application of bilateral thoracic paravertebral block (TPVB) in conjunction with general anesthesia for robotic-assisted partial hepatectomy without hepatic portal occlusion in a 62-year-old female patient diagnosed with Child-Pugh class B liver cirrhosis. The procedure resulted in minimal intraoperative blood loss (80mL), stable hemodynamics under low central venous pressure, and an exceptionally clear surgical field, facilitating precise dissection. This procedure also markedly reduces sedative/analgesic requirements for general anesthesia and causes rapid emergence. The patient experienced effective postoperative analgesia with minimal opioid consumption and achieved early recovery milestones. Conclusions: This case highlights the potential of bilateral TPVB to reduce hepatic sinusoidal pressure and decrease catecholamine secretion through selective visceral sympathetic nerve block. Thereby minimizing intraoperative bleeding and enhancing surgical field visualization without the need for hepatic portal occlusion. It presents a viable anesthetic strategy to optimize surgical conditions in minimally invasive hepatobiliary procedures, especially for high-risk patients with limited physiological reserve.
- 12 January 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1684794
Open AccessBilateral thoracic paravertebral block for robotic hepatectomy without hepatic portal occlusion for a cirrhosis patient: a case report
Background: Bilateral thoracic paravertebral block (TPVB) is a regional anesthesia technique used for perioperative analgesia in thoracic and abdominal surgeries. However, its application as a key component of anesthesia to optimize surgical conditions during robotic-assisted hepatectomy, particularly in patients with severe liver cirrhosis, is not well-documented. Case presentation: We present the successful application of bilateral thoracic paravertebral block (TPVB) in conjunction with general anesthesia for robotic-assisted partial hepatectomy without hepatic portal occlusion in a 62-year-old female patient diagnosed with Child-Pugh class B liver cirrhosis. The procedure resulted in minimal intraoperative blood loss (80mL), stable hemodynamics under low central venous pressure, and an exceptionally clear surgical field, facilitating precise dissection. This procedure also markedly reduces sedative/analgesic requirements for general anesthesia and causes rapid emergence. The patient experienced effective postoperative analgesia with minimal opioid consumption and achieved early recovery milestones. Conclusions: This case highlights the potential of bilateral TPVB to reduce hepatic sinusoidal pressure and decrease catecholamine secretion through selective visceral sympathetic nerve block. Thereby minimizing intraoperative bleeding and enhancing surgical field visualization without the need for hepatic portal occlusion. It presents a viable anesthetic strategy to optimize surgical conditions in minimally invasive hepatobiliary procedures, especially for high-risk patients with limited physiological reserve.
- Open Access
- 22 November 2025
- Published by Springer Nature in Molecular Cancer
- Vol. 25 (1)
Targeting SERPINB3–MAPK axis-mediated cuproptosis resistance enhances the response to antitumor immunotherapy
Cuproptosis, a newly identified form of cell death, is closely linked to copper homeostasis and protein lipoylation. Using a multi-omics approach, we firstly reveal that SERPINB3 confers cuproptosis resistance in pancreatic cancer and functions as a theranostic biomarker. Mechanistically, SERPINB3 inhibits FDX1 transcription by activating the MAPK signaling pathway, thereby conferring cuproptosis resistance. We further demonstrated that SERPINB3 directly interacts with MEK1, impeding its chaperone-mediated autophagic degradation, which ultimately leads to sustained activation of the MAPK signaling pathway. Additionally, we found that SERPINB3 promotes pancreatic cancer immune evasion by upregulating PD-L1 expression on tumor cells. This phenomenon motivated the development of a triple-combination strategy consisting of MAPK inhibition, cuproptosis induction, and αPD-1 therapy for pancreatic cancer patients with high SERPINB3 expression. To this end, we further developed a metal-organic framework (MOF) loaded with both copper ions and MEK inhibitor, which significantly triggers tumor-specific cuproptosis and enhances antitumor immunity. In summary, SERPINB3 serves as a predictive biomarker to inform therapeutic strategies targeting cuproptosis, thereby establishing a novel paradigm for cancer immunotherapy that integrates metal biology, targeted therapy, and immune modulation.
- 22 November 2025
- Published by Springer Nature in Molecular Cancer
- Vol. 25 (1)
Open AccessTargeting SERPINB3–MAPK axis-mediated cuproptosis resistance enhances the response to antitumor immunotherapy
Cuproptosis, a newly identified form of cell death, is closely linked to copper homeostasis and protein lipoylation. Using a multi-omics approach, we firstly reveal that SERPINB3 confers cuproptosis resistance in pancreatic cancer and functions as a theranostic biomarker. Mechanistically, SERPINB3 inhibits FDX1 transcription by activating the MAPK signaling pathway, thereby conferring cuproptosis resistance. We further demonstrated that SERPINB3 directly interacts with MEK1, impeding its chaperone-mediated autophagic degradation, which ultimately leads to sustained activation of the MAPK signaling pathway. Additionally, we found that SERPINB3 promotes pancreatic cancer immune evasion by upregulating PD-L1 expression on tumor cells. This phenomenon motivated the development of a triple-combination strategy consisting of MAPK inhibition, cuproptosis induction, and αPD-1 therapy for pancreatic cancer patients with high SERPINB3 expression. To this end, we further developed a metal-organic framework (MOF) loaded with both copper ions and MEK inhibitor, which significantly triggers tumor-specific cuproptosis and enhances antitumor immunity. In summary, SERPINB3 serves as a predictive biomarker to inform therapeutic strategies targeting cuproptosis, thereby establishing a novel paradigm for cancer immunotherapy that integrates metal biology, targeted therapy, and immune modulation.
- Open Access
- 23 August 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (12) , 9993-9994
A commentary on “Individualized blood pressure regulation and acute kidney injury in older patients having major abdominal surgery: a pilot randomized trial”
- 23 August 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (12) , 9993-9994
Open AccessA commentary on “Individualized blood pressure regulation and acute kidney injury in older patients having major abdominal surgery: a pilot randomized trial”
- Open Access
- 21 August 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (12) , 9946-9947
A commentary on “Preemptive left stellate ganglion block reduces the incidence and severity of cardiac surgery-associated acute kidney injury: a randomized clinical trial”
- 21 August 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (12) , 9946-9947
Open AccessA commentary on “Preemptive left stellate ganglion block reduces the incidence and severity of cardiac surgery-associated acute kidney injury: a randomized clinical trial”
- Open Access
- 23 July 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (12) , 9822-9823
A commentary on “Effects of dyclonine mucilage and compound lidocaine cream as tracheal catheter lubricant on postoperative pharyngeal complications after general anesthesia”
An abstract is unavailable. This article is available as a PDF only.
- 23 July 2025
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 111 (12) , 9822-9823
Open AccessA commentary on “Effects of dyclonine mucilage and compound lidocaine cream as tracheal catheter lubricant on postoperative pharyngeal complications after general anesthesia”
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 28 February 2025
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 19, 1525230
Serum-derived exosomal microRNAs as biomarkers for postoperative delirium
Introduction: Postoperative delirium (POD) is a frequent and challenging complication in elderly surgical patients, marked by abrupt cognitive and attentional disturbances. Current POD diagnosis depends on clinical assessments that are time-intensive and lack predictive accuracy before surgery. Although previous research has explored biomarkers such as neuroinflammatory factors and Alzheimer’s-related proteins to enhance POD prediction, single molecular markers have proven insufficient for reliable prognosis.Methods: This study investigated serum exosomal miRNA expression profiles in postoperative patients to assess their association with POD. We compared miRNA expression between POD and non-POD groups through cognitive assessments and serum analyses. Additionally, enrichment analysis was conducted to determine the biological pathways regulated by differentially expressed miRNAs.Results: Our analysis identified 57 miRNAs with significantly altered expression between POD and non-POD patients, including 16 upregulated and 41 downregulated miRNAs in the POD group. Enrichment analysis revealed that these miRNAs are involved in genes regulating neurotrophin signaling, neuroactive ligand-receptor interactions, and pathways that influence neuronal plasticity and cell viability.Discussion: This study highlights specific miRNAs as potential biomarkers for POD and suggests their involvement in the underlying mechanisms of cognitive decline following surgery. By enhancing diagnostic capabilities and identifying potential therapeutic targets, our findings could lead to more effective POD management strategies for elderly patients. Further research is recommended to validate these miRNAs and evaluate their clinical utility for predictive screening and therapeutic interventions.
- 28 February 2025
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 19, 1525230
Open AccessSerum-derived exosomal microRNAs as biomarkers for postoperative delirium
Introduction: Postoperative delirium (POD) is a frequent and challenging complication in elderly surgical patients, marked by abrupt cognitive and attentional disturbances. Current POD diagnosis depends on clinical assessments that are time-intensive and lack predictive accuracy before surgery. Although previous research has explored biomarkers such as neuroinflammatory factors and Alzheimer’s-related proteins to enhance POD prediction, single molecular markers have proven insufficient for reliable prognosis.Methods: This study investigated serum exosomal miRNA expression profiles in postoperative patients to assess their association with POD. We compared miRNA expression between POD and non-POD groups through cognitive assessments and serum analyses. Additionally, enrichment analysis was conducted to determine the biological pathways regulated by differentially expressed miRNAs.Results: Our analysis identified 57 miRNAs with significantly altered expression between POD and non-POD patients, including 16 upregulated and 41 downregulated miRNAs in the POD group. Enrichment analysis revealed that these miRNAs are involved in genes regulating neurotrophin signaling, neuroactive ligand-receptor interactions, and pathways that influence neuronal plasticity and cell viability.Discussion: This study highlights specific miRNAs as potential biomarkers for POD and suggests their involvement in the underlying mechanisms of cognitive decline following surgery. By enhancing diagnostic capabilities and identifying potential therapeutic targets, our findings could lead to more effective POD management strategies for elderly patients. Further research is recommended to validate these miRNAs and evaluate their clinical utility for predictive screening and therapeutic interventions.
- 17 July 2024
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (8) , 3135-3136
Letter to the Editor Regarding Effect of Zusanli Acupoint Injection with Anisodamine on Postoperative Recovery Quality of Patients Undergoing Bariatric Surgery
- 17 July 2024
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (8) , 3135-3136
Letter to the Editor Regarding Effect of Zusanli Acupoint Injection with Anisodamine on Postoperative Recovery Quality of Patients Undergoing Bariatric Surgery